Antibody Immunotherapy of Gram Negative Bacterial Sepsis - Medical Intelligence Unit (Hardback)

Gram negative bacterial infections occur frequently - more than 300,000 hospitalized patients develop serious gram negative bacterial infections each year in the US. Mortality of gram negative bacterial serpsis is greater than 10% and exceeds 30% in immunocompressed patients. The failure of conventional therapy has provided an impetus for the development of new adjuvant treatment of gram negative bacterial infections, such as the use of antibodies directed against endotoxin and endotoxin-induced monokines. This book describes the development of these new approaches and their clinical implementations.